China Is Top International Priority For AdvaMed's New Chairman
This article was originally published in PharmAsia News
Executive Summary
U.S. medical device association AdvaMed's new chairman, Jim Mazzo, cites regulatory roadblocks in China as the most important international marketing issue facing U.S. device manufacturers